[North Carolina] Panel passes embryonic stem cell research
By Gary D. Robertson,
Associated Press
| 07. 26. 2007
RALEIGH (AP) - The largest committee in the state House backed legislation Thursday setting rules for how research can be performed on human embryonic stem cells, even though the bill eliminated funding to encourage research.
The bill's primary sponsor is Rep. Earl Jones, D-Guilford.
The guidelines, approved by a 45-35 vote, would permit research on stem cells left over from in-vitro fertilization that would otherwise be discarded. But a $10 million appropriation was removed from the bill that would have helped the state Health and Wellness Trust Fund distribute grants to nonprofit groups conducting stem cell research.
The money was eliminated because it could take about a year for the trust fund to set up guidelines, Jones said. He said embryonic stem cells could offer a renewable source of replacement cells and tissues to treat Parkinson's and Alzheimer's diseases, spinal cord injuries and other conditions.
"People are dying from these diseases," said Rep. Larry Womble, D-Forsyth, who supports the bill. "If we can address that to save a whole lot of lives that we cannot save now ... this is...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...